Cell Biotech Co., Ltd. (KOSDAQ:049960)

Cell Biotech Revenue

Cell Biotech had revenue of 15.81B KRW in the quarter ending June 30, 2026, with 32.78% growth. This brings the company's revenue in the last twelve months to 60.40B, up 27.27% year-over-year. In the year 2025, Cell Biotech had annual revenue of 53.13B with 6.44% growth.

• Revenue (ttm): 60.40B
• Revenue Growth: +27.27%
• P/S Ratio: 1.79
• Revenue / Employee: 598.01M
• Employees: 101
• Market Cap: 108.13B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	53.13B	3.21B	6.44%
Dec 31, 2024	49.91B	-3.87B	-7.20%
Dec 31, 2023	53.79B	3.26B	6.46%
Dec 31, 2022	50.53B	3.65B	7.79%
Dec 31, 2021	46.87B	1.29B	2.83%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error